Timothy Lin

17PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Probability theoryAdversarial machine learningPredictive and prognostic markersApplied statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 04, 2026
TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival.

|May 01, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Jul 03, 2025
Generative AI in Medicine: Pioneering Progress or Perpetuating Historical Inaccuracies? Cross-Sectional Study Evaluating Implicit Bias.

Philip Sutera, Rohini Bhatia, Timothy Lin

|Jan 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.

Alexander D Sherry, Yufei Liu, Pavlos Msaouel

|Jan 08, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.

Avital M Miller, Adina H Passy, Alexander D Sherry

|Dec 10, 2024
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.

Troy J Kleber, Alexander D Sherry, Andrew J Arifin

Pageof 3

Frequent Collaborators

14 joint publications

Ethan B Ludmir

11 joint publications

Alexander D Sherry

10 joint publications

Ramez Kouzy

9 joint publications

Pavlos Msaouel